$SIGA Technologies Inc(SIGA)$SIGA Therapeutics (NASDAQ:SIGA) has dropped 32% in late Friday afternoon trading after a U.S. FDA monkeypox update stated that the company smallpox antiviral Tpoxx (tecovirimat) has not demonstrated efficacy or safety in human studies.Buy the dip?